More disadvantageda | Less disadvantageda | |||
---|---|---|---|---|
Females | ||||
10–19 years | 947 | 746 | ||
(excl. screening follow-upb) | 784 | 573 | ||
20–29 years | 2,061 | 2,610 | ||
(excl screening follow-upb) | 1,594 | 1,955 | ||
30–39 years | 1,034 | 1,308 | ||
(excl screening follow-upb) | 834 | 1,020 | ||
Males | ||||
10–19 years | 118 | 144 | ||
20–29 years | 956 | 1,636 | ||
(anal site involvedc) | 429 | 798 | ||
(anal site NOT involvedc) | 436 | 645 | ||
30–39 years | 654 | 1,146 | ||
Major citiesd | Other areasd | |||
More disadvantaged | Less disadvantaged | More disadvantaged | Less disadvantaged | |
Females | ||||
10–19 years | 349 | 563 | 598 | 183 |
20–29 years | 984 | 2,171 | 1,077 | 439 |
30–39 years | 561 | 1,123 | 473 | 185 |
Males | ||||
20–29 years | 506 | 1,402 | 450 | 234 |
(anal site involvedc) | 257 | 699 | 172 | 99 |
(anal site NOT involvedc) | 196 | 532 | 240 | 113 |
30–39 years | 376 | 1,004 | 278 | 142 |